Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 May 10;55(20):6071-4.
doi: 10.1002/anie.201600521. Epub 2016 Apr 8.

Efficient Synthesis of Molecular Precursors for Para-Hydrogen-Induced Polarization of Ethyl Acetate-1-(13) C and Beyond

Affiliations

Efficient Synthesis of Molecular Precursors for Para-Hydrogen-Induced Polarization of Ethyl Acetate-1-(13) C and Beyond

Roman V Shchepin et al. Angew Chem Int Ed Engl. .

Abstract

A scalable and versatile methodology for production of vinylated carboxylic compounds with (13) C isotopic label in C1 position is described. It allowed synthesis of vinyl acetate-1-(13) C, which is a precursor for preparation of (13) C hyperpolarized ethyl acetate-1-(13) C, which provides a convenient vehicle for potential in vivo delivery of hyperpolarized acetate to probe metabolism in living organisms. Kinetics of vinyl acetate molecular hydrogenation and polarization transfer from para-hydrogen to (13) C via magnetic field cycling were investigated. Nascent proton nuclear spin polarization (%PH ) of ca. 3.3 % and carbon-13 polarization (%P13C ) of ca. 1.8 % were achieved in ethyl acetate utilizing 50 % para-hydrogen corresponding to ca. 50 % polarization transfer efficiency. The use of nearly 100% para-hydrogen and the improvements of %PH of para-hydrogen-nascent protons may enable production of (13) C hyperpolarized contrast agents with %P13C of 20-50 % in seconds using this chemistry.

Keywords: MRI; contrast agents; ethyl acetate; hyperpolarization; para-hydrogen induced polarization (PHIP).

PubMed Disclaimer

Figures

Figure 1
Figure 1
a) Molecular addition of para-H2 to vinyl acetate1-13C (VA-1-13C) followed by polarization transfer resulting in 13C hyperpolarized ethyl acetate-1-13C (13C HP EA-1-13C); b) Conversion profile for vinyl acetate (VA, 80 mM, in methanol-d4, at ~40 °C temperature maintained by the 9.4 T NMR spectrometer) hydrogenation reaction in four pressure regimes; c) Dependence of “HA” signal of hyperpolarized ethyl acetate (1H HP EA) on the para-H2 bubbling duration at the Earth’s magnetic field (resulting in ALTADENA[24]-type spectrum shown in inset); d) (Top) schematic representation of experimental setup for magnetic field cycling: hydrogenation is carried out at the Earth’s magnetic field, the sample then is quickly moved inside -metal shield (with magnetic field BFC) and slowly transferred from the shield for subsequent NMR detection; (bottom) schematic magnetic field profile during the field cycling; e) Dependence of HP 1-13C NMR signal (shown in the insert) of ethyl acetate (13C HP EA) on the BFC; f) Thermal spectrum of 13C signal reference sodium acetate-1-13C (~2.0 M).; g) 13C HP spectrum of natural abundance 80 mM ethyl acetate (13C HP EA). Note the resonances labeled with ° correspond to HP 13C resonances originating from hydrogenation catalyst (Figure S7); h) HP 13C spectrum of 80 mM ethyl acetate-1-13C (13C HP EA-1-13C).
Figure 2
Figure 2
13C 3D MRI of (a) a hollow spherical plastic ball partially filled with 80 mM HP EA-1-13C and (b) a plastic sphere (~2.8 mL) filled with thermally polarized 4.3 M sodium acetate-1-13C reference phantom. Both 3D true-FISP images were acquired using 15 mm OD round RF surface coil tuned to 163.4 MHz in 15.2 T small-animal Bruker MRI scanner (see SI for additional details). One representative slice is shown for each 3D image.
Scheme 1
Scheme 1
a) Reaction scheme for the preparation of vinyl acetate-1-13C (VA-1-13C). b) Generalized scheme for preparation of potential targets with vinylated carboxyl groups.

References

    1. Abragam A, Goldman M. Rep. Prog. Phys. 1978;41:395–467.
    2. Goodson BM. J. Magn. Reson. 2002;155:157–216. - PubMed
    3. Nikolaou P, Goodson BM, Chekmenev EY. Chem. Eur. J. 2015;21:3156–3166. - PMC - PubMed
    1. Kurhanewicz J, Vigneron DB, Brindle K, Chekmenev EY, Comment A, Cunningham CH, DeBerardinis RJ, Green GG, Leach MO, Rajan SS, Rizi RR, Ross BD, Warren WS, Malloy CR. Neoplasia. 2011;13:81–97. - PMC - PubMed
    2. Brindle KM. J. Am. Chem. Soc. 2015;137:6418–6427. - PubMed
    3. Comment A, Merritt ME. Biochemistry. 2014;53:7333–7357. - PMC - PubMed
    4. Golman K, in't Zandt R, Thaning M. Proc. Natl. Acad. Sci. U. S. A. 2006;103:11270–11275. - PMC - PubMed
    5. Bhattacharya P, Chekmenev EY, Perman WH, Harris KC, Lin AP, Norton VA, Tan CT, Ross BD, Weitekamp DP. J. Magn. Reson. 2007;186:150–155. - PMC - PubMed
    1. Ardenkjaer-Larsen JH, Fridlund B, Gram A, Hansson G, Hansson L, Lerche MH, Servin R, Thaning M, Golman K. Proc. Natl. Acad. Sci. U. S. A. 2003;100:10158–10163. - PMC - PubMed
    2. Shchepin RV, Coffey AM, Waddell KW, Chekmenev EY. Anal. Chem. 2014;86:5601–5605. - PMC - PubMed
    1. Nelson SJ, Kurhanewicz J, Vigneron DB, Larson PEZ, Harzstark AL, Ferrone M, van Criekinge M, Chang JW, Bok R, Park I, Reed G, Carvajal L, Small EJ, Munster P, Weinberg VK, Ardenkjaer-Larsen JH, Chen AP, Hurd RE, Odegardstuen LI, Robb FJ, Tropp J, Murray JA. Sci. Transl. Med. 2013;5:198ra108. - PMC - PubMed
    1. Bowers CR, Weitekamp DP. Phys. Rev. Lett. 1986;57:2645–2648. - PubMed
    2. Eisenschmid TC, Kirss RU, Deutsch PP, Hommeltoft SI, Eisenberg R, Bargon J, Lawler RG, Balch AL. J. Am. Chem. Soc. 1987;109:8089–8091.
    3. Bowers CR, Weitekamp DP. J. Am. Chem. Soc. 1987;109:5541–5542.

Publication types